Will Wegovy's price go up — and what does that mean for you?

The myth: Wegovy prices are fixed and predictable

A lot of people searching this question have spotted something real: the price they were quoted six months ago is not the price they see today. That instinct is correct. The idea that GLP-1 medicine prices sit still is the misconception worth addressing first.

What has happened is straightforward. Eli Lilly revised Mounjaro's UK list price significantly from 1 September 2025, the highest dose's list price moved from around £122 to around £330 per four-week pen, as widely reported at the time. Wegovy, made by Novo Nordisk, operates in the same market, and private providers set their own prices partly in response to wholesale costs, so movement in one product creates pressure across the category. None of this is hidden; it is simply how pricing works when two manufacturers hold the majority of a rapidly growing market.

For people wondering specifically about the UK trajectory, the honest answer is that private prices have risen since these medicines gained momentum, and whether Wegovy is getting cheaper is a question we look at in detail if you want to understand how the current trend reads. We've written a detailed look at how Wegovy's price has already changed if you want the timeline rather than the projection.

What headline prices usually leave out, and why that matters for your actual bill

The number quoted on a provider's homepage is often just the medicine cost. Prescription fees, clinical consultation charges, delivery fees and any ongoing dose-review support can sit entirely outside that figure. Some providers bundle these; many do not. A £149 headline can become considerably more once you add a consultation fee on top, pay separately for delivery, or discover that dose-increase reviews carry an extra charge.

This matters when you are trying to judge whether a price rise affects you personally. If your current provider charges separately for each element, a rise in the medicine's wholesale cost hits your bill in a transparent way. If those elements are bundled, the change may show up in a revised monthly figure without much explanation. Either way, ask what is included before committing.

The full cost of Wegovy treatment page covers what a realistic monthly spend looks like when you account for the whole picture rather than the headline number.

nume's position on price, honest, not promotional

We are not going to tell you we are the cheapest option. We are not, and we are not trying to be. What we offer is one transparent price that covers the consultation, the prescription, the treatment, delivery and seven-day aftercare with no hidden extras and no subscription pulling money from your account without a fresh clinical review.

If you order by midday Monday to Friday and your consultation is approved, your treatment leaves our GPhC-registered pharmacy the same day and arrives with you the next working day via DPD. Worth noting: if your payday lands on a Monday and you're hoping to get started that week, ordering before noon gives you the best chance of having your pen before the working week is out.

Every repeat order goes through the same clinical review process, a real prescriber reads your notes, not software. You can meet our clinical team here. On the question of whether Wegovy's price will keep rising, we apply the same increases as the supply chain dictates; our current treatment pricing is always shown on the treatment page, and we do not obscure changes behind a low teaser rate.

Why price is the wrong test for a prescription medicine

Here is the part that gets lost in the price conversation. Wegovy is a prescription-only medicine, it cannot legally be sold without a valid prescription issued after a genuine clinical assessment. When you see a price that is dramatically lower than the market range, or a seller offering these medicines without a formal consultation, that is a red flag, not a bargain.

The MHRA has warned publicly and repeatedly about counterfeit weight-loss pens circulating through online and social-media channels. Fake pens have contained the wrong substances entirely, including insulin in some cases, and have led to hospitalisations. The right test for any provider of these medicines is not the price; it is whether they are on the GPhC pharmacy register, whether prescribers are named and qualified, and whether your identity and weight are verified before anything is dispensed. The MHRA's Yellow Card scheme lets you report any suspect seller, and the MHRA encourages people to use it.

If you want to understand whether treatment makes sense for your situation before committing to any price, our weight-loss treatment overview is a good place to start, or you can go straight to a free consultation with our prescribers. The clinical review costs you nothing; you only pay if treatment is approved and you choose to proceed. If you are also thinking about results and want a realistic picture of how much weight you might lose on Wegovy, that page sets out what the evidence actually shows. There is also more context on whether costs might ease in the other direction at our page on whether Wegovy will come down in price, and a closer look at the broader pricing outlook on our page covering whether Wegovy prices will fall.